South Africa Continues to Resist Anti-AIDs Efforts
Pharmaceutical Executive
Capetown-In March, ruling on a case initiated by the Treatment Action Campaign, Save Our Babies, and the Children's Rights Centre, Judge Chris Botha ordered the South African government to provide the anti-retroviral nevirapine to all HIV-positive pregnant women.
Capetown-In March, ruling on a case initiated by the Treatment Action Campaign, Save Our Babies, and the Children's Rights Centre, Judge Chris Botha ordered the South African government to provide the anti-retroviral nevirapine to all HIV-positive pregnant women.
Although Botha gave the government the right to appeal his decision, he mandated that the medicines be kept available while any appeal is pending. Considering it unlikely that his decision would be reversed, he said it would save some lives even if it was overturned on appeal.
Health ministry spokesman Sibani Mngadi said the government would consider whether to appeal after the African National Congress discussed it at a national executive meeting. The ANC chastised former US president Jimmy Carter for telling the South African government that it could learn much from the AIDS policies of African countries that were smaller and poorer than its own. An ANC spokesman accused Carter of urging the country to treat its people as guinea pigs to further the interests of the pharmaceutical industry.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
